David Redfern
Director/Board Member presso ASPEN PHARMACARE HOLDINGS LIMITED
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
David Simon Redfern is currently the Chairman at ViiV Healthcare Ltd., Director at Human Genome Sciences, Inc., Non-Executive Director at Aspen Pharmacare Holdings Ltd., and Director at GlaxoSmithKline Consumer Healthcare Holdings Ltd.
He previously served as the President-Corporate Development at GSK Plc.
Prior to his current positions, he was a Director at Haleon UK Holdings (No.2) Ltd.
and a Principal at PricewaterhouseCoopers Services Ltd.
Mr. Redfern obtained his undergraduate degree from the University of Bristol.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
GSK PLC
0.00% | 16/04/2024 | 163 910 ( 0.00% ) | 4 M $ | 31/03/2024 |
Posizioni attive di David Redfern
| Società | Posizione | Inizio |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/05/2008 |
| ASPEN PHARMACARE HOLDINGS LIMITED | Director/Board Member | 01/02/2015 |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Chairman | 01/04/2011 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Director/Board Member | 30/07/2012 |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
 GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The private company is based in Brentford, UK. | Director/Board Member | - |
Precedenti posizioni note di David Redfern
| Società | Posizione | Fine |
|---|---|---|
Haleon UK Holdings (No.2) Ltd.
 Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. functions as an investment holding private company. The company is based in Weybridge, UK and was founded in 2019. | Director/Board Member | 18/07/2022 |
Formazione di David Redfern
| University of Bristol | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GSK PLC | Health Technology |
| ASPEN PHARMACARE HOLDINGS LIMITED | Health Technology |
| Aziende private | 4 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The private company is based in Brentford, UK. | Finance |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Part of Haleon Plc, Haleon UK Holdings (No.2) Ltd. functions as an investment holding private company. The company is based in Weybridge, UK and was founded in 2019. | Finance |
- Borsa valori
- Insiders
- David Redfern
